Alexandra Andersson, PhD,  —

Alexandra holds a BSc in psychology with continued studies in neuroscience and pharmacology. She also holds an interdisciplinary Med. Licentiate, merging the fields of neuropharmacology, psychiatry and immunology from the Karolinska Institute, Stockholm, Sweden. Her previous research focused on interaction between the immune- and neurotransmitter systems regarding psychotic disorders.

Articles by Alexandra Andersson

Tracleer and Ventavis Combo as Initial Therapy Seen to Benefit Patients with Advanced PAH

An initial combination treatment with Tracleer (bosentan) and Ventavis (iloprost, inhalation solution) dramatically improved exercise capacity and clinical function in patients with pulmonary arterial hypertension (PAH), compared to treatment with either of those medications alone. The study, “Treatment of pulmonary arterial hypertension using initial combination therapy of…

A Conversation With Rare Disease Advocates